AVANIR Pharmaceuticals (NASDAQ:AVNR)

CAPS Rating: 2 out of 5

A pharmaceutical company focused on developing, acquiring and commercializing novel therapeutic products for the treatment of chronic diseases.

Recs

0
Player Avatar Shankapotamus (< 20) Submitted: 12/16/2011 12:38:23 PM : Outperform Start Price: $1.82 AVNR Score: +43.51

Technical bounce.

Report this Post Reply

Featured Broker Partners


Advertisement